Clinical Decision Support Market by Component (Service, Hardware, Software), Application (Prescription Decision Support, Information Retrieval), Delivery Mode (Web Based, Standalone, Integrated) & Region for 2024-2031
Report ID: 2117|No. of Pages: 202
Clinical Decision Support Market by Component (Service, Hardware, Software), Application (Prescription Decision Support, Information Retrieval), Delivery Mode (Web Based, Standalone, Integrated) & Region for 2024-2031
Clinical Decision Support Market Valuation – 2024-2031
The global Clinical Decision Support (CDS) market is being driven by rising demand for advanced healthcare solutions, rising chronic illness prevalence and government measures to promote digital health. CDS tools improve healthcare practitioners’ decision-making by combining data analytics with evidence-based guidelines. This is likely to enable the market size surpass USD 1.4 Billion valued in 2023 to reach a valuation of around USD 3.3 Billion by 2031.
CDS systems, both integrated and standalone, are used in hospitals, clinics and diagnostic centers. North America dominates the market because to its strong healthcare infrastructure, while Asia-Pacific is predicted to grow the fastest, owing to increasing healthcare investments and technological developments. The rising demand for Clinical Decision Support is enabling the market grow at a CAGR of 11.21% from 2024 to 2031.
>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=2117
Clinical Decision Support Market: Definition/ Overview
Clinical Decision Support (CDS) refers to health information technology solutions that help healthcare providers make educated clinical decisions. It combines data analytics, patient information, and medical recommendations to improve care. CDS is used in healthcare to provide recommendations, alerts and reminders about diagnostics, treatment alternatives and patient care. It reduces errors, improves efficiency, and provides tailored care, all of which lead to better patient outcomes. In the future, CDS will include powerful AI, predictive analytics and real-time data from wearable devices. This will result in more targeted, evidence-based care and improved health outcomes.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=2117
Will Increasing Adoption of Electronic Health Records (EHRs) to Boost the Clinical Decision Support Market Growth?
The growing adoption of Electronic Health Records (EHRs) accelerates the growth of the Clinical Decision Support (CDS) industry. According to the Office of the National Coordinator for Health Information Technology (ONC), approximately 96% of non-federal acute care hospitals in the United States have embraced certified EHR technology by 2021. This ubiquitous EHR connectivity allows for the seamless adoption of CDS systems, giving healthcare clinicians access to real-time decision support tools. These tools help improve clinical decision-making, which leads to improved patient outcomes and fewer errors. Furthermore, the interoperability of EHRs and CDS systems promotes data exchange, improves workflow efficiency and enables individualized patient care. As healthcare organizations prioritize patient safety and quality treatment, the demand for integrated CDS systems alongside EHRs is projected to increase, driving the overall market expansion.
Will High Production Costs Hamper the Clinical Decision Support Market?
High production costs impede the growth of the Clinical Decision Support (CDS) market, particularly for smaller healthcare facilities. According to research published in the Journal of the American Medical Informatics Association, the initial cost of a comprehensive Electronic Health Record (EHR) system with CDS integration is between $15,000 and $70,000 per practitioner. For mid-sized hospitals, these expenditures can reach the millions, posing significant financial barriers to CDS adoption.
Furthermore, continuing maintenance, training and software updates increase overall costs, making it harder for smaller institutions to justify their investment. The high costs may dissuade healthcare practitioners from exploring advanced decision support systems, reducing patient care quality and safety. As a result, addressing the financial barriers is crucial for fostering wider adoption and realizing the full potential of CDS solutions in improving clinical outcomes.
Category-Wise Acumens
Will Increasing Demand for Accurate Medication Management Drive the Prescription Decision Support segment?
The growing requirement for precise drug management is likely to propel the Prescription Decision Support (PDS) segment. This trend is being driven by factors such as an increase in prescription mistakes and bad drug responses. Enhanced regulatory requirements for patient safety, as well as a rising emphasis on individualized treatment, are driving up the demand for effective medication management solutions. Furthermore, integration of Prescription Decision Support systems into Electronic Health Records (EHRs) is recommended, allowing for real-time professional guidance during prescribing operations.
As healthcare professionals work to improve patient outcomes, their dependence on PDS tools is expected to grow. The necessity for better medication reconciliation processes and the management of complex prescription regimens is recognized, establishing a conducive environment for the expansion of the Prescription Decision Support market.
Will Increasing Accessibility and Convenience of Healthcare Technology Drive the Web-Based Segment?
The growing accessibility and ease of healthcare technology is predicted to drive the expansion of the web-based segment in healthcare. The growing usage of smartphones and tablets, as well as the availability of high-speed internet, have made online healthcare solutions more accessible to both patients and clinicians. Furthermore, the COVID-19 pandemic has intensified the focus on remote care and telehealth solutions, resulting in an increase in demand for web-based platforms that enable virtual consultations and monitoring.
The growing desire for patient-centered care models has compelled healthcare providers to implement web-based technologies that improve patient involvement and streamline procedures. Web-based solutions provide ease with features like online appointment scheduling, electronic prescriptions and simple access to health records increasingly favored by both patients and healthcare professionals, fostering further expansion in this segment.
Gain Access to Clinical Decision Support Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=2117
Country/Region-wise Acumens
Will Increasing Prevalence of Chronic Diseases Drive the Market in North America?
The rising frequency of chronic diseases is driving the Clinical Decision Support (CDS) market in North America. According to the Centers for Disease Control and Prevention (CDC), by 2022, almost 6 out of 10 adults in the United States will have a chronic disease, with 4 out of 10 suffering from two or more disorders. The development in chronic illnesses increases the demand for improved CDS technologies that improve patient care management and optimize treatment methods.
As healthcare providers grapple with the challenges of managing various chronic illnesses, CDS systems are increasingly acknowledged for their ability to assist clinical decision-making. These technologies contribute to fewer medical errors, more efficient treatment processes and individualized care plans, all of which lead to better patient outcomes. Therefore, the urgent need to address chronic disease management is expected to propel the adoption of CDS solutions, solidifying their role in the evolving healthcare landscape of North America.
Will Increasing Healthcare Expenditure and Infrastructure Development Drive the Market in Asia Pacific Region?
Increasing healthcare spending and infrastructure development are significant drivers of the Clinical Decision Support (CDS) industry in Asia Pacific. According to the World Bank, healthcare spending in East Asia and the Pacific region increasing from 6.4% of GDP in 2000 to 7.1% in 2019, demonstrating an increasing commitment to upgrading healthcare systems. This increasing trend in spending is projected to continue, encouraging investment in innovative technology.
Countries such as South Korea have stated plans to invest around USD 1.7 Billion USD in AI healthcare technologies, hence increasing the use of advanced CDS systems. This investment intends to improve healthcare delivery by reducing processes, making better decisions and eventually raising patient care standards. As healthcare infrastructure continues to develop and modernize, the demand for sophisticated CDS solutions increases that can leverage data for better clinical outcomes is anticipated to grow significantly, driving market expansion across the region.
Competitive Landscape
The Clinical Decision Support Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.
Some of the prominent players operating in the Clinical Decision Support Market include McKesson Corporation, Oracle (Cerner Corporation), Siemens Healthineers GmbH, Allscripts Healthcare, LLC, athenahealth, Inc., NextGen Healthcare, Inc., Koninklijke Philips N.V, IBM Corporation, Agfa-Gevaert Group, Wolters Kluwer N.V.
Latest Developments
- In October 2023, Wolters Kluwer Health announced AI Labs, a community resource to integrate generative AI with UpToDate, its CDS service, allowing medical practitioners to make better-informed decisions.
- In August 2023, GE HealthCare announced CardioVisio for Atrial Fibrillation, a patient-centric, digital CDS solution to enable precision care.
- In February 2023, EBSCO Information Services introduced additional capabilities to the DynaMedex Mobile App to better clinical decision support. These upgrades improve users’ mobile experience by enabling physicians to efficiently deliver evidence-based patient care.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2018-2031 |
| Growth Rate | CAGR of ~11.21% from 2024 to 2031 |
| Base Year for Valuation | 2023 |
| Historical Period | 2020-2022 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis. |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | McKesson Corporation, Oracle (Cerner Corporation), Siemens Healthineers GmbH, Allscripts Healthcare, LLC, athenahealth, Inc., NextGen Healthcare, Inc., Koninklijke Philips N.V, IBM Corporation, Agfa-Gevaert Group, Wolters Kluwer N.V. |
| Customization | Report customization along with purchase available upon request |
Clinical Decision Support Market, By Category
Component
- Service
- Hardware
- Software
Application
- Medical Diagnosis
- Alerts and Reminders
- Prescription Decision Support
- Information Retrieval
Delivery Mode
- Web Based
- Standalone
- Integrated
Geography
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL CLINICAL DECISION SUPPORT MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CLINICAL DECISION SUPPORT MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY COMPONENT
5.1 Overview
5.2 Services
5.3 Hardware
5.4 Software
6 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY PRODUCT
6.1 Overview
6.2 Integrated
6.3 Standalone
7 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY DELIVERY MODE
7.1 Overview
7.2 Cloud-Based
7.3 Web-Based
7.4 On-Premise
8 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY APPLICATION
8.1 Overview
8.2 Conventional
8.3 Advanced
9 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY TYPE
9.1 Overview
9.2 Therapeutic
9.2 Diagnostic
10 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY USER INTERACTIVITY
10.1 Overview
10.2 Active
10.3 Passive
11 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY MODEL
11.1 Overview
11.2 Knowledge-Based
11.3 Non-Knowledge-Based
12 GLOBAL CLINICAL DECISION SUPPORT MARKET, BY GEOGRAPHY
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 U.K.
12.3.3 France
12.3.4 Rest of Europe
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Rest of Asia Pacific
12.5 Latin America
12.5.1 Brazil
12.5.2 Argentina
12.6 Rest of the World
13 GLOBAL CLINICAL DECISION SUPPORT MARKET COMPETITIVE LANDSCAPE
13.1 Overview
13.2 Company Market Share
13.3 Vendor Landscape
13.4 Key Development Strategies
14 COMPANY PROFILES
14.1 Cerner Corporation
14.1.1 Overview
14.1.2 Financial Performance
14.1.3 Product Outlook
14.1.4 Key Developments
14.2 EPIC Systems Corporation
14.2.1 Overview
14.2.2 Financial Performance
14.2.3 Product Outlook
14.2.4 Key Developments
14.3 Mckesson Corporation
14.3.1 Overview
14.3.2 Financial Performance
14.3.3 Product Outlook
14.3.4 Key Developments
14.4 Meditech
14.4.1 Overview
14.4.2 Financial Performance
14.4.3 Product Outlook
14.4.4 Key Developments
14.5 Philips Healthcare
14.5.1 Overview
14.5.2 Financial Performance
14.5.3 Product Outlook
14.5.4 Key Developments
14.6 Zynx Health
14.6.1 Overview
14.6.2 Financial Performance
14.6.3 Product Outlook
14.6.4 Key Developments
14.7 Elsevier B.V.
14.7.1 Overview
14.7.2 Financial Performance
14.7.3 Product Outlook
14.7.4 Key Developments
14.8 IBM Corporation
14.8.1 Overview
14.8.2 Financial Performance
14.8.3 Product Outlook
14.8.4 Key Developments
14.9 Allscripts Healthcare Solutions, Inc
14.9.1 Overview
14.9.2 Financial Performance
14.9.3 Product Outlook
14.9.4 Key Developments
14.10 Wolters Kluwer Health
14.10.1 Overview
14.10.2 Financial Performance
14.10.3 Product Outlook
14.10.4 Key Developments
15 Appendix
15.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
